Search clinical trials for: MDP

Total 260 results

University Hospital, Rouen

Unknown

MEdical Versus SUrgical Treatments of Rectal Endometriosis (MESURE)

Endometriosis

France
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.
PPD

Completed

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Asthma

United States, Bulgaria, Croatia, Hungary, Israel, Poland, Serbia, Spain, Ukraine
Odense University Hospital

Unknown

Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding

Peptic Ulcer Bleeding

Denmark
Beth Israel Deaconess Medical Center

Completed

Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

Sialorrhea

United States
Kaunas University of Medicine
Pharmacosmos A/S; Orivas, Lithuania

Unknown

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

Colorectal Neoplasms | Anemia, Iron-Deficiency | Colorectal Surgery | Intravenous Drug Usage

Lithuania
Molecular NeuroImaging
Institute for Neurodegenerative Disorders

Completed

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Alzheimer's Disease (AD) | Tauopathies | Parkinson's Disease (PD) | Progressive Supranuclear Palsy (PSP) | Chronic Traumatic Encephalopathy (CTE) | Frontal Temporal Dementia (FTD) | Pick's Disease

United States
University Hospital, Brest

Completed

Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD (EMI II)

Chronic Obstructive Pulmonary Disease

France
National Taiwan University Hospital

Unknown

Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication

Gastroesophageal Reflux Disease

Taiwan
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan

Unknown

Optical Tomographic Scanner for Skin Lesions

Skin Cancer, Benign Skin Tumor, Inflammatory Skin Disease

Taiwan
Bial - Portela C S.A.

Completed

The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics

Parkinson's Disease (PD)

France
Centre d'Investigation Clinique et Technologique...
Fondation Garches; Fondation Paul Bennetot

Unknown

Interest of Combining Speech Therapy With a Non-invasive Brain Stimulation (tDCS) for the Aphasic Patient (Taph)

Aphasia

France
Bial - Portela C S.A.

Completed

Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

Parkinson's Disease (PD)
Assistance Publique - Hôpitaux de Paris

Unknown

Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease (IBDOT)

Inflammatory Bowel Disease

France
Instituto de Investigación Marqués de Valdecilla
Ministerio de Economía y Competitividad, Spain

Unknown

Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents. (C-Endys)

Cardiovascular Diseases | Hepatitis C

Spain
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

Parkinson's Disease (PD)

Portugal
Sanofi

Completed

A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis (TENERE)

Multiple Sclerosis

Hungary, Belgium, Germany, Italy, Greece, France, Poland, Spain, Canada, Switzerland, Czech Republic, Tunisia, United Kingdom
Parc de Salut Mar
University of Barcelona

Unknown

Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive Biomarkers

Colon Cancer

Spain
Instituto de Investigación Marqués de Valdecilla
Ministerio de Economía y Competitividad, Spain

Unknown

Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC) (CICHepC)

Hepatitis C

Spain
Assistance Publique - Hôpitaux de Paris

Unknown

Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma (OPTIMUM)

Melanoma BRAF V600E/K Mutated | CDNKN2A Loss Defined

France
Assistance Publique - Hôpitaux de Paris

Unknown

Early Diagnosis of Mycosis Fungoides (DIAPREMYF)

Cutaneous T Cell Lymphoma

France
Bial - Portela C S.A.

Completed

Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067

Parkinson's Disease (PD)

France
Bial - Portela C S.A.

Completed

Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics

Parkinson's Disease (PD)

France
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Parkinson's Disease (PD)

Portugal
St. Joseph's Healthcare Hamilton

Unknown

Partnership in Medication Management (PIMM) in Patients With Mood Disorders (PIMM)

Bipolar Disorder | Major Depressive Disorder

Canada
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide

Parkinson's Disease (PD)

Portugal
Bial - Portela C S.A.

Completed

An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites

Parkinson's Disease (PD)

Netherlands
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety Study of Albuterol Spiromax® in Subjects With Asthma

Asthma

United States
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa

Parkinson's Disease (PD)

Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Asthma

United States
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa

Parkinson's Disease (PD)

Canada
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide

Parkinson's Disease (PD)

Canada
Mannkind Corporation

Completed

A 2-Month Safety Follow-Up Trial

Type 1 Diabetes | Type 2 Diabetes

United States, Brazil, Canada, Russian Federation
Mannkind Corporation

Completed

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

Diabetes Type 2

Brazil, Spain, United States, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
Mannkind Corporation

Completed

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

Diabetes, Type I

United States, Spain, Brazil, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
Mannkind Corporation

Completed

Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Brazil, Spain, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, Ukraine, Czech Republic
UCB Pharma

Completed

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery (NEUPOS)

Parkinson's Disease

Germany
Chaitanya Hospital, Pune

Unknown

Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy. (mdp)

Muscular Dystrophy | Duchenne Muscular Dystrophy,

India
National Cancer Institute (NCI)

Completed

Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer

Recurrent Prostate Cancer | Bone Metastases | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura

Purpura, Schoenlein-Henoch

France
New York Institute of Technology
Michael J. Fox Foundation for Parkinson's Research

Completed

The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease

Parkinson's Disease

United States
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Exhaled Air Temperature (TAE) As A Marker Of Airway Inflammation In Asthma

ASTHMA

Spain
Medical University of Lodz

Unknown

PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases

Healthy | Asthma | Allergic Rhinitis | Atopic Dermatitis | Urticaria

Poland
Bausch & Lomb Incorporated

Completed

Comparative Study of the Wearing Satisfaction of Two Soft Contact Lens Designs.

Myopia

Japan
Medical University of Lodz

Unknown

Exercise-induced Bronchoconstriction in School Children

Asthma

Poland
University of Sao Paulo General Hospital
Novartis

Unknown

The Use of Zoledronic Acid to Complex Regional Pain Syndrome (Aclasta)

Complex Regional Pain Syndromes

Brazil
Mitsubishi Tanabe Pharma Corporation

Completed

Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke

Cerebral Infarction

3

Subscribe